Concepedia

Xuanlong Du

XD

Statistics

Publications

7

Citations

235

H-Index

7

Active since

2020

Affiliations

Second Affiliated Hospital of Nanjing Medical University(Current)

Southeast University

Nantong University

Affiliated Hospital of Nantong University

Zhongda Hospital Southeast University

Xuanlong Du is an author at Second Affiliated Hospital of Nanjing Medical University specializing in oncology, medicine, and molecular oncology.

Publications per year

2020–2024

7

Publications

7

Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer

Pengcheng Zhou, Xuanlong Du, Weilu Jia et al. · Signal Transduction and Targeted Therapy · 2024 · 69 citations · Full text

Medicine, Cancer Biology, Oncology +17

Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma

Xuanlong Du, Yewei Zhang · Frontiers in Genetics · 2020 · 66 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

pH-Responsive Pluronic F127–Lenvatinib-Encapsulated Halogenated Boron-Dipyrromethene Nanoparticles for Combined Photodynamic Therapy and Chemotherapy of Liver Cancer

Jingjing Zong, Hao Peng, Zhe Fan et al. · ACS Omega · 2021 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database

Haidong Zhang, Xuanlong Du, Hui Dong et al. · BMC Gastroenterology · 2022 · 29 citations · Full text

Medicine, Biostatistics, Oncology +17

Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma

Xuanlong Du, Pengcheng Zhou, Haidong Zhang et al. · Cell Death and Disease · 2023 · 18 citations · Full text

Medicine, Genetics, Oncology +17

1–5 of 7